Active substanceMepivacaineMepivacaine Similar drugsTo uncover Mepivacaine DF solution for injections HIRATRADE, JV LLC Russia Mepivastezin solution for injections 3M Deutschland GmbH Scandinibes solution for injections Laboratory of Inibes SA Spain Scandonaut solution for injections The Septodont France Dosage form: & nbspInjection. Pharmacotherapeutic group:Local anesthetic. ATX: & nbspN.01.B.B.03 MepivacaineN.01.B.B Amides Pregnancy and lactation:There is no data on the use of mepivacaine for local anesthesia during pregnancy. Experiments on animals do not give sufficient data on the possible effects of mepivacaine on the course of pregnancy, fetal development, childbirth and postnatal development of the child.Mepivacaine penetrates the placental barrier.When appointing mepivacaine in the first trimester of pregnancy, the risk of adverse effects on fetal development can not be ruled out, so its use in the early period of pregnancy is possible only in the absence of other local anesthetics.There are no data on the penetration of mepivacaine into breast milk. If it is necessary to use the drug during lactation, refrain from breastfeeding for 24 hours after use. Form release / dosage:Injection 30 mg / ml. Packaging:Cartridge (50) / 1,7 ml in glass cartridges, 50 cartridges, together with the instructions for use in a tin can. / - tin can Terms of leave from pharmacies:On prescription Registration number:П N011570 / 01 Date of registration:06.12.2007 / 11.09.2012 Expiration Date:Unlimited The owner of the registration certificate:3M Deutschland GmbH3M Deutschland GmbH Manufacturer: & nbsp3M Deutschland GmbH Germany Representation: & nbsp3M Russia ZAO3M Russia ZAO Information update date: & nbsp2016-08-24 Illustrated instructions × Illustrated instructions Instructions